製品名:oxetan-3-one

IUPAC Name:oxetan-3-one

CAS番号:6704-31-0
分子式:C3H4O2
純度:95%+
カタログ番号:CM104041
分子量:72.06

包装単位 有効在庫 価格(USD) 数量
CM104041-100g in stock ŔǕň
CM104041-500g in stock șňŔ
CM104041-1000g in stock ŭƩǕ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:6704-31-0
分子式:C3H4O2
融点:-
SMILESコード:O=C1COC1
密度:
カタログ番号:CM104041
分子量:72.06
沸点:
MDL番号:MFCD09263255
保管方法:

Category Infos

Oxetanes
Oxygen heterocycles are one of the most common heterocycles in drugs and natural products. Oxetene has high polarity and is also a good acceptor for hydrogen bond, which contributes to the metabolism and chemical stability of its host molecules. When substituted for commonly used functional groups such as gem dimethyl or carbonyl, oxetane units can induce profound changes in water solubility, lipophilicity, metabolic stability and conformational preference. Four of the FDA-approved drugs contain oxetenes: Orlistat, Paclitaxel, and two of its derivatives, Docetaxel and Cabazitaxel. Currently, oxetane-containing building blocks are flourishing in medicinal chemistry and drug discovery.

Column Infos

Alicyclic Heterocycles
When the ends of the chains are joined together into a ring, cyclic compounds result; such substances often are referred to as carbocyclic or alicyclic compounds. Substitution of one or more of the ring carbon atoms in the molecules of a carbocyclic compound with a heteroatom gives a heterocyclic compound.
Fenebrutinib
Roche’s investigational drug, Fenebrutinib has shown brain penetration and significant reduction in lesions in patients with relapsing multiple sclerosis (MS) from the recent release of new data from Phase II FENopta study. Fenebrutinib is a potent and highly selective Bruton’s tyrosine kinase (BTK) inhibitor, and currently the only reversible inhibitor being tested in Phase III MS trials. BTK inhibitor is involved in key pathological features of MS, including B-cell development and activation.

Related Products